Continuing Pharmacy Education / CE Master List / “I don’t dig your cig” : Strategies for tobacco cessation-RECORDED WEBINAR
Please use this button to register in our system as a new user, or to purchase a CE Activity.
For free CE's, returning users can simply click the "TAKE TEST/EVALUATION" button on the right.
Please use this button when you have completed the CE Activity and are ready to take the quiz and complete the evaluation.

“I don’t dig your cig” : Strategies for tobacco cessation-RECORDED WEBINAR

The Arthur E. Schwarting Symposium is an educational conference focused on pharmacy practice for pharmacists in many settings.

This year's sympoisum had an overall topic of Drug Induced Disease from a Patient Safety perspective.  This presentation deals with secondary cancers resulting from primary cancer treatment.

Learning Objectives

·  Recall the medicinal uses of tobacco
·  Describe the cycle of tobacco addition
·  Identify strategies for counseling patients on behavioral techniques recommended for tobacco cessation
·   Compare the safety and efficacy of FDA approved pharmacotherapies for tobacco cessation
·    Discuss recommendations from national practice guidelines for tobacco cessation and apply them to a patient case

Activity Release Dates

Released:  April 27, 2023
Expires:  April 27, 2026

Course Fee

$17 Pharmacist

ACPE UAN Codes

 0009-0000-23-012-H01-P

Session Code

23RW12-VXK92

Accreditation Hours

1.0 hours of CE

Accreditation Statement

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this application-based activity and will receive 1.0 CE Hour  for completing the activity  (ACPE UAN 0009-0000-23-011-H01-P), passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Grant Funding

There is no grant funding for this activity.

Faculty

Stefanie Nigro, PharmD, BCACP, CDCES,
Associate Clinical Professor
Department of Pharmacy Practice
University of Connecticut School of Pharmacy
Storrs, CT

Faculty Disclosure

Dr. Nigro has no financial relationship with inelegible companies

Disclaimer

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Content

Post Test Pharmacist

    1. Which patient characteristic supports initiation of combination therapy for smoking cessation?
      1. Age younger than 65 years
      2. Elevated eosinophil levels
      3. Heavy smoker with high dependence

     

    1. When should patients begin varenicline relative to their quit date if they are following an approach with a traditional fixed quit date?
      1. 1 week prior
      2. 3 days prior
      3. The same day

     

    1. Which of the following treatments for smoking cessation requires a dose adjustment for renal impairment?
      1. Nicotine lozenge
      2. Bupropion SR
      3. Varenicline

     

    1. Which of the following combinations is the most effective for smoking cessation?
    2. Combination NRT
    3. Bupropion SR + nicotine patch
    4. Varenicline + nicotine patch

     

    1. Which statement correctly describes the comparative efficacy of first-line smoking cessation monotherapies?
    2. Bupropion SR is more effective than NRT
    3. All NRTs are more effective than varenicline
    4. Varenicline is more effective than NRT or bupropion SR

     

    1. Why can’t women who are younger than 35 who smoke 15 or more cigarettes per day use estrogen containing contraceptives?
    2. A pharmacokinetic drug interaction decreases contraceptive efficacy and increases risk for adverse effects
    3. A pharmacodynamic drug interaction increases risk of venous thromboembolism, myocardial infarction and stroke
    4. A pharmacokinetic drug interaction increases estrogen levels and also magnifies estrogen-like side effects

     

    1. Patients should be counseled to avoid eating or drinking 15 minutes prior to the use of which therapies?
    2. Nicotine lozenge, gum and inhaler
    3. Nicotine lozenge and gum
    4. Nicotine nasal spray, gum and lozenge

     

     

    1. Which of the following smoking cessation therapies does NOT match with the listed side effect?
    2. Nicotine gum and vivid dreams
    3. Nicotine nasal spray and nasal irritation
    4. Bupropion SR and tremor

     

     

    1. Chad is a 55-year-old male patient with a past medical history including diabetes mellitus type 2, hyperlipidemia, hypertension, and chronic obstructive pulmonary disease. He is currently hospitalized due to a myocardial infarction but is now stable Chad recognizes that quitting smoking is critical to his cardiovascular health and wants to try to quit. Which of the following therapies is a first-line recommendation for Chad to initiate while hospitalized, according to the American College of Cardiology?  

     

    1. Pharmacotherapy is contraindicated 2 weeks post myocardial infarction
    2. Combination therapy with Chantix and NRT
    3. Combination NRT

     

     

    1. Melissa is a 34-year-old female who has smoked two packs per day since she was 19 years old. She comes to the pharmacy and asks if there is a medication that can help her feel ‘readier’ to quit. She does not feel ready to set a quit date but wants to try and work toward this goal. Which of the following medications can Melissa start now with a goal of reducing smoking?
    2. Chantix or NRT
    3. Any of the first-line medications
    4. Bupropion SR